News

Over 1,200 NObreath® FeNO devices sold since the 2024 UK guideline update. Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1...

Asthma is a chronic disease that affects millions worldwide, with many dying from the condition every year1. Asthma care has evolved over the years, but despite the advances, objectively assessing airway inflammation, the key driver of asthma, remains challenging in...

Written by Carol Stonham MBE This article reflects the opinions of a healthcare professional. The views expressed are their own. The intended use for the NObreath® is as follows: The 2nd generation NObreath® is a breath nitric oxide (NO) test...

Small Intestinal Bacterial Overgrowth (SIBO) is a gastrointestinal condition where an abnormal number of bacteria is found in the small intestine. Whilst small amounts of bacteria are normal, higher levels can cause uncomfortable digestive issues. SIBO can impact nutritional absorption...

Almost 10 months after the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) released an updated joint guideline for asthma care and management, a major milestone has been...

Tobacco kills more than 7 million people each year, including an estimated 1.6 million non-smokers exposed to second-hand smoke.1 It is estimated that tobacco costs the global economy more than $1.4 trillion a year in healthcare costs and lost productivity.2...